Overview

A Study of LY3023703 Testing Pain Relief After Wisdom Teeth Removal

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to test if a single dose of LY3023703 relieves pain after wisdom teeth removal. The study will last about one week for each participant, not including screening.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Celecoxib